A_comparative,_randomized_study_of_low-dose_human_menopausal_gonadotropin_and_follicle-stimulating_hormone_in_women_with_polycystic_ovarian_syndrome._Treatment_with_low-dose_follicle-stimulating_hormone_(FSH)_is_associated_with_a_high_rate_of_ovulation_in_anovulatory_women_with_polycystic_ovarian_syndrome_(PCOS),_but_it_is_not_clear_whether_the_success_of_treatment_is_because_of_the_use_of_pure_FSH_or_the_low_dose_of_gonadotropin._We_undertook_a_randomized_controlled_study_to_compare_the_effects_of_urinary_FSH_and_human_menopausal_gonadotropin_(hMG)_using_a_low-dose_regimen_in_30_women_with_PCOS._Each_subject_received_a_maximum_of_three_cycles_of_either_FSH_or_hMG._Ovulation_occurred_in_75%_of_subjects_and_in_77%_of_cycles_induced_with_FSH_and_in_94%_of_women,_85%_of_cycles_of_those_treated_with_hMG._A_single_dominant_follicle_developed_in_70%_(FSH)_and_65%_(hMG)_of_cycles,_respectively._Five_singleton_pregnancies_occurred_in_each_group._This_study_shows_that_low-dose_FSH_and_hMG_are_equally_successful_in_inducing_ovulation,_suggesting_that_the_success_of_treatment_depends_on_the_low_dose_of_gonadotropin_used_rather_than_the_presence_or_absence_of_luteinizing_hormone_in_the_preparation.